I Raad

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi Chelator-based catheter lock solutions in eradicating organisms in biofilm
    I Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Antimicrob Agents Chemother 57:586-8. 2013
  2. ncbi Diagnosis of catheter-related bloodstream infections: is it necessary to culture the subcutaneous catheter segment?
    I I Raad
    The University of Texas M D Anderson Cancer Center, Department of Infectious Diseases, Infection Control and Employee Health, Houston 77030, USA
    Eur J Clin Microbiol Infect Dis 20:566-8. 2001
  3. ncbi Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections
    Issam I Raad
    The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Clin Infect Dis 42:1726-34. 2006
  4. ncbi Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients
    Issam Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 94:1032-6. 2002
  5. ncbi Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL
    Issam Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Chest 121:1171-6. 2002
  6. ncbi Intravascular catheter-related infections: new horizons and recent advances
    Issam I Raad
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Arch Intern Med 162:871-8. 2002
  7. ncbi Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions
    Issam I Raad
    The M D Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Clin Infect Dis 42:1398-403. 2006
  8. ncbi Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm
    Issam I Raad
    Department of Infectious Diseases, Infection Control and Employee Health Unit 402, The University of Texas M D Anderson Cancer Center, P O Box 301402, Houston, Texas 77230 1402, USA
    Antimicrob Agents Chemother 49:5046-50. 2005
  9. ncbi Catheter-related vancomycin-resistant Enterococcus faecium bacteremia: clinical and molecular epidemiology
    Issam I Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Infect Control Hosp Epidemiol 26:658-61. 2005
  10. ncbi Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin
    Issam I Raad
    Department of Infectious Diseases, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Antimicrob Agents Chemother 48:3583-5. 2004

Collaborators

Detail Information

Publications108 found, 100 shown here

  1. ncbi Chelator-based catheter lock solutions in eradicating organisms in biofilm
    I Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Antimicrob Agents Chemother 57:586-8. 2013
    ..M-EDTA-25% ETOH was able to fully eradicate all biofilms within 2 h. MB-CIT was only effective against immature biofilms but was unable to fully eradicate most of the mature biofilms tested...
  2. ncbi Diagnosis of catheter-related bloodstream infections: is it necessary to culture the subcutaneous catheter segment?
    I I Raad
    The University of Texas M D Anderson Cancer Center, Department of Infectious Diseases, Infection Control and Employee Health, Houston 77030, USA
    Eur J Clin Microbiol Infect Dis 20:566-8. 2001
    ....
  3. ncbi Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections
    Issam I Raad
    The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Clin Infect Dis 42:1726-34. 2006
    ..Antifungal therapy is often required for long periods. Safety data from the clinical development program of the triazole antifungal agent, posaconazole, were analyzed...
  4. ncbi Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients
    Issam Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 94:1032-6. 2002
    ..Two prospective studies confirmed this finding but included a small number of IPA cases...
  5. ncbi Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL
    Issam Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Chest 121:1171-6. 2002
    ..To assess the value of Aspergillus polymerase chain reaction (PCR) test performed on the BAL in diagnosing invasive pulmonary aspergillosis (IPA)...
  6. ncbi Intravascular catheter-related infections: new horizons and recent advances
    Issam I Raad
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Arch Intern Med 162:871-8. 2002
    ....
  7. ncbi Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions
    Issam I Raad
    The M D Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Clin Infect Dis 42:1398-403. 2006
    ..Posaconazole is a broad-spectrum antifungal agent with in vitro and in vivo activity against Fusarium species...
  8. ncbi Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm
    Issam I Raad
    Department of Infectious Diseases, Infection Control and Employee Health Unit 402, The University of Texas M D Anderson Cancer Center, P O Box 301402, Houston, Texas 77230 1402, USA
    Antimicrob Agents Chemother 49:5046-50. 2005
    ..In biofilm, daptomycin and minocycline were the most active antibiotics against VREF, and linezolid was the least active...
  9. ncbi Catheter-related vancomycin-resistant Enterococcus faecium bacteremia: clinical and molecular epidemiology
    Issam I Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Infect Control Hosp Epidemiol 26:658-61. 2005
    ..To study the clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium organisms causing catheter-related bacteremia in patients with cancer...
  10. ncbi Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin
    Issam I Raad
    Department of Infectious Diseases, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Antimicrob Agents Chemother 48:3583-5. 2004
    ..More than 6 months after their clinical use, a decrease in susceptibility was noted for only linezolid at 83%. This was related in part to a single G2576U gene mutation in domain V of the 23S rRNA gene...
  11. ncbi Relationship between myalgias/arthralgias occurring in patients receiving quinupristin/dalfopristin and biliary dysfunction
    Issam Raad
    M D Anderson Cancer Center, Department of Infectious Diseases, 1515 Holcombe Blvd, Unit 402, Houston, TX 77030, USA
    J Antimicrob Chemother 53:1105-8. 2004
    ..To determine whether myalgias/arthralgias occurring in cancer patients who receive quinupristin/dalfopristin are associated with biliary tract dysfunction...
  12. ncbi Management of central venous catheters in patients with cancer and candidemia
    Issam Raad
    Department of Infectious Diseases, Infection Control and Employee Health, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Clin Infect Dis 38:1119-27. 2004
    ..03). CVC removal < or =72 h after onset should be considered in patients with suspected catheter-related candidemia who have no evidence of dissemination, recent corticosteroid therapy, or chemotherapy...
  13. ncbi Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections
    Issam Raad
    Departments of Infectious Diseases, Infection Control and Employee Health, University of Texas M D Anderson Cancer Center, Texas 77030, USA
    J Antimicrob Chemother 53:646-9. 2004
    ..The objective of this study was to compare the safety and efficacy of the two drugs in the treatment of VREF infections in cancer patients...
  14. ncbi In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces
    Issam Raad
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Antimicrob Agents Chemother 47:3580-5. 2003
    ..01). We concluded that M-EDTA is highly active in eradicating microorganisms embedded in fresh and mature biofilm adhering to catheter surfaces...
  15. ncbi Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters
    I Raad
    Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77230 1402, USA
    Eur J Clin Microbiol Infect Dis 26:549-56. 2007
    ..In addition to critical illness and persistent neutropenia, quantitative blood cultures might be useful in predicting outcomes for neutropenic patients with catheter-related bloodstream infections...
  16. ncbi Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits
    Issam Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Antimicrob Agents Chemother 46:327-32. 2002
    ..06). In conclusion, the M-EDTA catheter flush solution was highly efficacious in preventing catheter-related colonization, bacteremia, septic phlebitis, and endocarditis in rabbits...
  17. ncbi Intravascular catheters impregnated with antimicrobial agents: a milestone in the prevention of bloodstream infections
    I Raad
    The University of Texas, M D Anderson Cancer Center, Section of Infection Control, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Support Care Cancer 7:386-90. 1999
    ..In conclusion, antimicrobial catheters have been shown to be highly cost effective in decreasing the risk of catheter-related bloodstream infection...
  18. ncbi Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi
    Issam Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Antimicrob Agents Chemother 56:935-41. 2012
    ..Our study shows that novel CHX-M/R-coated catheters have unique properties in completely inhibiting biofilm colonization of MRSA, VRE, P. aeruginosa, and fungi in a manner superior to that of M/R- and chlorhexidine-treated catheters...
  19. ncbi The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes
    Issam I Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States
    Biomaterials 32:2689-94. 2011
    ..Future animal and clinical studies are warranted to determine whether the gardine- and gendine-coated ETTs can significantly reduce the risk of VAP...
  20. ncbi Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain?
    Issam Raad
    The University of Texas MD Anderson Cancer Center, Houston and 2Kadlec Medical Center, Richland, Washington, USA
    Clin Infect Dis 49:1187-94. 2009
    ..In this study, we used strict definitions of coagulase-negative staphylococcal bacteremia to determine the impact of CVC retention on response to and recurrence of infection...
  21. ncbi Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study
    I Raad
    Department of Internal Medicine Specialties, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
    Ann Surg Oncol 8:179-86. 2001
    ..Nosocomial pneumonia continues to be associated with high morbidity and mortality in cancer patients...
  22. ncbi Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm
    Issam I Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Int J Antimicrob Agents 32:515-8. 2008
    ..04). In patients with catheter-related candidaemia when catheter removal is not feasible, the combination of ABLC+EDTA may be considered for antifungal catheter lock solution as part of a catheter salvage therapy...
  23. ncbi Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime
    Issam I Raad
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Cancer 98:1039-47. 2003
    ....
  24. ncbi Commentary: zero tolerance for catheter-related bloodstream infections: the unnegotiable objective
    Issam I Raad
    University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Infect Control Hosp Epidemiol 29:951-3. 2008
  25. ncbi Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria
    I Raad
    The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Antimicrob Chemother 62:746-50. 2008
    ....
  26. ncbi The role of chelators in preventing biofilm formation and catheter-related bloodstream infections
    Issam I Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Curr Opin Infect Dis 21:385-92. 2008
    ..This review focuses on recent advances in the role of chelators in biofilm disruption and prevention of catheter-related bloodstream infections...
  27. ncbi Intravascular catheter-related infections: advances in diagnosis, prevention, and management
    Issam Raad
    Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Lancet Infect Dis 7:645-57. 2007
    ....
  28. ncbi Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocycline
    I Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4095, USA
    Antimicrob Agents Chemother 45:3202-4. 2001
    ..The response rate was 68%, and the most frequent adverse event was arthralgia or myalgia (36%). Q-D-MIN is effective for VRE infection in cancer patients but is associated with a substantial frequency of arthralgia or myalgia...
  29. ncbi Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin
    I I Raad
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Leukemia 22:496-503. 2008
    ..03). In conclusion, posaconazole salvage therapy demonstrated greater efficacy and safety than HD-LPD/AMB alone or in combination with caspofungin in the salvage therapy of invasive aspergillosis in hematologic malignancy...
  30. ncbi In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections
    R Garcia
    University of Texas M D Anderson Cancer Center, Department of Medical Specialties, Houston 77030, USA
    Eur J Clin Microbiol Infect Dis 15:933-6. 1996
    ..Its activity was similar to that of vancomycin but superior to that of teicoplanin. Quinupristin/dalfopristin may prove to be an important addition to our armamentarium against catheter-related staphylococcal infections...
  31. ncbi Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients
    S Konoplev
    Department of Blood and Marrow Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Bone Marrow Transplant 27:877-81. 2001
    ....
  32. ncbi Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients
    G Ghanem
    Department of Infectious Diseases, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Infect Control Hosp Epidemiol 28:1054-9. 2007
    ....
  33. ncbi Mycobacterium kansasii infections in patients with cancer
    K L Jacobson
    Section of Infectious Diseases, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Clin Infect Dis 30:965-9. 2000
    ..The infections responded well to rifampin-based antimycobacterial regimens. M. kansasii is an infrequent but serious cause of pulmonary and, occasionally, disseminated disease in patients with cancer...
  34. ncbi Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia
    R V Fleming
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
    Leuk Lymphoma 40:511-20. 2001
    ..AmBisome was better tolerated than ABLC but was associated with mild abnormalities in liver function tests at the end of therapy...
  35. ncbi Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia
    Nathan P Wiederhold
    The University of Houston College of Pharmacy, Houston, TX 77030, USA
    J Antimicrob Chemother 55:792-5. 2005
    ..CONCLUSIONS: Lack of activity against biofilm-embedded organisms appeared to be the primary reason for microbiological failure of both drugs in the model...
  36. ncbi The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer
    Gerald P Bodey
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Am J Med 112:380-5. 2002
    ..glabrata than against C. albicans (20/38 [53%] vs. 57/74 [77%], P = 0.008). CONCLUSION: C. glabrata has emerged as an important cause of candidemia, especially among neutropenic patients who receive fluconazole prophylaxis...
  37. ncbi Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005
    Souad Youssef
    Department of Infectious Diseases, M D Anderson Cancer Center, Houston, Texas 77030, USA
    Medicine (Baltimore) 86:69-77. 2007
    ..It is noteworthy that there were no cases of extrapulmonary organ infection in HSCT recipients who presented with S. pneumoniae infection at our institution...
  38. ncbi Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus
    Harrys A Torres
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    Diagn Microbiol Infect Dis 46:25-8. 2003
    ..group than in the A. fumigatus one. The Aspergillus species distribution in IA cases in our institution shows a predominance of the more antifungal-resistant or -tolerant non-fumigatus Aspergillus spp...
  39. ncbi The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients
    Ghazi Ghanem
    University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Infect Control 36:656-60. 2008
    ....
  40. ncbi Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality
    Harrys A Torres
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA
    Clin Lymphoma Myeloma 6:393-8. 2006
    ..01). CONCLUSION: In an era of intense and pleiotropic immunosuppressive therapy in patients with lymphoma, CMV-A and CMV-D are significant infections. Preventive strategies might be warranted for patients at risk...
  41. ncbi Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients
    R Y Hachem
    Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Clin Microbiol 47:129-33. 2009
    ..The diagnostic marker BG was shown to have a higher sensitivity than that of GM in detecting IA and other mold infections in hematologic malignancy patients...
  42. ncbi Adenovirus infections in adult recipients of blood and marrow transplants
    A M La Rosa
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Clin Infect Dis 32:871-6. 2001
    ..The need for an effective, nontoxic antiviral therapy is apparent...
  43. ncbi Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study
    Georgios Chamilos
    Department of Infectious Diseases and Infection Control, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Ther 29:1980-6. 2007
    ..Because LFT abnormalities are multifactorial in severely immunocompromised patients, uncertainty remains regarding the clinical significance of these laboratory findings...
  44. ncbi Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity
    Dimitrios P Kontoyiannis
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD. Anderson Cancer Center, Houston 77030, USA
    Infect Control Hosp Epidemiol 23:542-5. 2002
    ..CONCLUSIONS: In breakthrough candidemia, the same risk factors seen in de novo candidemia were encountered, although more frequently. C. glabrata and C. krusei are the leading causes of breakthrough candidemia in patients with cancer...
  45. ncbi Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies
    Karen J Vigil
    The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1460, Houston, TX 77030, USA
    Clin Infect Dis 50:374-80. 2010
    ..Pyomyositis is typically caused by gram-positive bacteria, especially Staphylococcus aureus. Few cases of Escherichia coli pyomyositis have been reported, including only 1 involving a patient with a hematologic malignancy...
  46. ncbi Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?
    I Raad
    University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Infect Control Hosp Epidemiol 22:136-9. 2001
    ..To determine the safety and cost-effectiveness of replacing the intravenous (IV) tubing sets in hospitalized patients at 4- to 7-day intervals instead of every 72 hours...
  47. ncbi Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center
    H Hanna
    Department of Internal Medicine Specialties, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
    Infect Control Hosp Epidemiol 22:217-9. 2001
    ..Multifaceted infection control measures, including decontamination of the environment and of nondisposable equipment, halted the nosocomial transmission of VRE in the MICU...
  48. ncbi Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli
    Michail S Lionakis
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Diagn Microbiol Infect Dis 52:15-20. 2005
    ..These Aspergillus isolates were found to be AMB-resistant by the more sensitive E-test method...
  49. ncbi Multiple-species candidemia in patients with cancer
    Maha R Boktour
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 101:1860-5. 2004
    ....
  50. ncbi Phaeohyphomycosis in a tertiary care cancer center
    Ronen Ben-Ami
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Infect Dis 48:1033-41. 2009
    ..To assess the range of clinical presentations and outcomes of phaeohyphomycosis in patients with cancer, we reviewed cases diagnosed at the M. D. Anderson Cancer Center (Houston, TX)...
  51. ncbi Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy
    Anastasia Antoniadou
    Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Medicine (Baltimore) 82:309-21. 2003
    ..04, but not in univariate analysis), indicating the complexity of the variables that influence the response to antifungal treatment in cancer patients with candidemia...
  52. ncbi Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients
    J Cairo
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Centre, Houston, TX 77030, USA
    Clin Microbiol Infect 17:1711-6. 2011
    ....
  53. ncbi blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program
    H Aboufaycal
    The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Microbiol 45:614-5. 2007
    ..The isolates had distinct ribotype and pulsed-field gel electorphoresis patterns and appeared independently, remote in time and location, at the same cancer center...
  54. ncbi The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer
    S Youssef
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Antimicrob Chemother 61:421-4. 2008
    ..Previous authors have reported that administration of vitamin B6 with linezolid reversed pancytopenia in two patients...
  55. ncbi Comparing clinical and microbiological methods for the diagnosis of true bacteraemia among patients with multiple blood cultures positive for coagulase-negative staphylococci
    I Al Wohoush
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Clin Microbiol Infect 17:569-71. 2011
    ..The CDC clinical criteria had low accuracy, which can be improved by speciation, particularly if the patient had more than two positive blood cultures...
  56. ncbi Catheter-related Corynebacterium bacteremia: should the catheter be removed and vancomycin administered?
    S Ghide
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1460, Houston, TX 77030, USA
    Eur J Clin Microbiol Infect Dis 29:153-6. 2010
    ..Treatment with a systemic active antibiotic over a 7-day period appears to be adequate for resolution of the infection...
  57. ncbi Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center
    Harrys A Torres
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas, Unit 402, M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA
    Eur J Cancer 41:2268-79. 2005
    ..01). The presentation of GI-CMVd varies according to the type of cancer, and AIDS. GI-CMVd is associated with a high mortality among cancer patients, particularly those with disseminated CMV disease or AIDS...
  58. ncbi Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study
    Nikolaos V Sipsas
    Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Int J Antimicrob Agents 34:95-8. 2009
    ....
  59. ncbi Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection
    Russell E Lewis
    University of Houston College of Pharmacy, Houston, Texas 77030, USA
    Antimicrob Agents Chemother 46:3499-505. 2002
    ..Lack of in vitro antifungal activity against biofilm-encased organisms appeared to be the primary reason for mycological failure of antifungal regimens in the model...
  60. ncbi Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients
    H A Hanna
    University of Texas M.D. Anderson Cancer Center, Section of Infection Control, Houston 77030, USA
    Infect Control Hosp Epidemiol 22:165-6. 2001
    ..through central venous catheters was a risk factor for CR BSI, whereas thrombocytopenia during catheterization may have provided protection against CR BSI, as did central venous catheter insertion under maximal sterile barrier precautions..
  61. ncbi Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005
    Amar Safdar
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Medicine (Baltimore) 86:324-33. 2007
    ..47; p < 0.007) were less likely to die from infection. More effective measures for surveillance and prevention of late cytomegalovirus and varicella zoster virus infections in children with CBT and chronic GVHD are needed...
  62. ncbi Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis
    Michail S Lionakis
    Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, USA
    Antimicrob Agents Chemother 50:294-7. 2006
    ..PNT-preexposed mice had significantly improved survival and reduced fungal burden compared to amphotericin B-preexposed and untreated mice. PNT-treated mice had increased survival but no difference in fungal burden versus untreated mice...
  63. ncbi Efficacy of antimicrobial-impregnated silicone sections from penile implants in preventing device colonization in an animal model
    Rabih O Darouiche
    Center for Prostheses Infection and Infectious Disease Section, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas 77030, USA
    Urology 59:303-7. 2002
    ..aureus and protect against staphylococcal colonization of devices implanted for 2 days in animals...
  64. ncbi Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins
    S Ghosh
    Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Bone Marrow Transplant 28:271-5. 2001
    ....
  65. ncbi A comparison of galactomannan-ELISA and a newly developed galactomannan-LATEX test in the serologic diagnosis of invasive aspergillosis in patients with hematologic malignancies
    X Keutgen
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Eur J Clin Microbiol Infect Dis 26:655-8. 2007
    ..Both tests demonstrated a specificity of 99%. The GM-LATEX test demonstrated a superior sensitivity in terms of detecting galactomannan and thus may be useful in the diagnosis of IA in patients with HM...
  66. ncbi Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
    Ray Y Hachem
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Cancer 112:1282-7. 2008
    ..There are limited data comparing the efficacy and safety of these 2 agents in the treatment of IA in patients with cancer...
  67. ncbi Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution
    Roy F Chemaly
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas77030 4009, USA
    Medicine (Baltimore) 88:211-20. 2009
    ..Patients with refractory pneumonia had a relatively low clinical response rate in our study...
  68. ncbi Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis
    Amar Safdar
    Immunology Research Program, Department of Infectious Diseases, Infection Control and Employee Health, The Anderson Cancer Center, Houston, Texas 77030, USA
    Medicine (Baltimore) 89:236-44. 2010
    ..09; n = 839); the 7 remaining studies were more homogenous by Breslow-Day test (p = 0.054). Our results suggest that nephrotoxicity is generally similar for ABLC and L-AmB in patients receiving antifungal therapy and prophylaxis...
  69. ncbi Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study
    Roy F Chemaly
    Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 17:1499-506. 2010
    ..We experienced an increased incidence of MRSA surgical-site infections (MRSA SSIs) at our institution. However, to our knowledge, no studies have evaluated the risk factors and outcomes of MRSA SSIs in cancer patients...
  70. ncbi Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome
    Dimitrios P Kontoyiannis
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Scand J Infect Dis 36:564-9. 2004
    ..01). TS is associated with a high mortality rate in cancer patients. The spectrum of infection at our institution has shifted from a predominance of disseminated infection to CVC-related fungemias without evidence of tissue invasion...
  71. ncbi Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?
    Coralia N Mihu
    Department of Infectious Diseases, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Cancer 116:5290-6. 2010
    ..Furthermore, clinical studies suggested that this combination may improve response of invasive aspergillosis (IA)...
  72. ncbi Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection
    Nikolaos V Sipsas
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 115:4745-52. 2009
    ....
  73. ncbi Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002)
    Padmavati Kumashi
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Medicine (Baltimore) 84:303-12. 2005
    ..pneumoniae, and other conventional predictors of unfavorable outcome were not associated with increased mortality rates in these high-risk patients with cancer...
  74. ncbi The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients
    Javier A Adachi
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Am J Infect Control 37:442-6. 2009
    ..The objective was to evaluate the impact of molecular identification of clonal multidrug-resistant (MDR) P aeruginosa strains and the implementation of infection control measures...
  75. ncbi Risk of bioaerosol contamination with Aspergillus species before and after cleaning in rooms filtered with high-efficiency particulate air filters that house patients with hematologic malignancy
    Linda D Lee
    Department of Environmental Health and Safety, The University of Texas M D Anderson Cancer Center, Houston, TX 77230, USA
    Infect Control Hosp Epidemiol 28:1066-70. 2007
    ....
  76. ncbi Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation
    Dimitrios P Kontoyiannis
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 110:1303-6. 2007
    ..Laboratory studies have demonstrated that iron is essential for Aspergillus growth and virulence...
  77. ncbi Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
    Dimitrios P Kontoyiannis
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 98:292-9. 2003
    ..Therefore, the authors retrospectively evaluated the efficacy and toxicity of CAS plus liposomal amphotericin B (LipoAMB) in patients with documented (definite or probable) or possible IA...
  78. ncbi Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis
    Dimitrios P Kontoyiannis
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 103:2334-7. 2005
    ..Itraconazole (ITC), a triazole with activity against Aspergillus, has been used in combination with AMB or lipid formulations of AMB (LipoAMB) in the treatment of IA, although the efficacy of this strategy is uncertain...
  79. ncbi Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases
    Dimitrios P Kontoyiannis
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Infect Dis 191:1350-60. 2005
    ..Anecdotal evidence suggests a rise in zygomycosis in association with voriconazole (VRC) use in immunosuppressed patients...
  80. ncbi Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones
    Kenneth V I Rolston
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Diagn Microbiol Infect Dis 51:215-8. 2005
    ..The newer quinolones (gatifloxacin, moxifloxacin, and garenoxacin) had better activity than ofloxacin, levofloxacin, and ciprofloxacin, against many other nonfermenters (Stenotrophomonas maltophilia, P. fluorescens, and P. putida)...
  81. ncbi The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation
    Amar Safdar
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 103:731-9. 2005
    ..The authors sought to evaluate the safety of adjuvant recombinant interferon-gamma-1b as an immune-modulatory therapy HSCT recipients...
  82. ncbi Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections
    Amar Safdar
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 101:2859-65. 2004
    ..The authors sought to determine the impact of high-dose (approximately 5.5 x 10(10) cells) GTX in patients with candidemia...
  83. ncbi Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center
    Roy F Chemaly
    Department of Infectious Diseases, Infection Control and Employee Health, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Medicine (Baltimore) 85:278-87. 2006
    ..HSCT recipients and patients with hematologic malignancies who develop upper respiratory infection due to CRVs should be considered for antiviral therapy of proven efficacy to reduce the risk of pneumonia and death...
  84. ncbi Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies
    Ray Y Hachem
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
    Cancer 101:1594-600. 2004
    ..fumigatus as the most common cause of IA. In the current study, the authors compared the risk factors and outcomes associated with IA caused by A. terreus and IA caused by A. fumigatus...
  85. ncbi Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection
    Bita Esmaeli
    Ophthalmology Section, Department of Infectious Disease, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas, USA
    Retina 23:118-9. 2003
  86. ncbi Evaluation of the silver iontophoretic catheter in an animal model
    Ray Y Hachem
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas, M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Biomaterials 24:3619-22. 2003
    ..1 to 2.23 microg/l with a mean of 0.62 (+/-0.44 SD). In conclusion SIC were safe with normal serum silver levels and were not associated with any local or systemic toxicity...
  87. ncbi Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity
    Dimitrios P Kontoyiannis
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas, M D Anderson Cancer Center, Houston, TX, USA
    Diagn Microbiol Infect Dis 47:415-9. 2003
    ..fumigatus to itraconazole resulted in dose-dependent enhanced effects of caspofungin and vice versa. Our finding suggests a preferential role for azole-caspofungin sequential combinations and merits further in vivo investigation...
  88. ncbi Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients
    Hend A Hanna
    Department of Infectious Diseases, Infection Control, and Employee Health Unit 402, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Chest 124:1030-8. 2003
    ..To evaluate the impact of using central venous catheters (CVCs) impregnated with the combination of minocycline and rifampin on nosocomial bloodstream infections (BSIs), morbidity, and mortality in cancer patients in the ICU...
  89. ncbi Cytomegalovirus pneumonia in patients with lymphoma
    Roy F Chemaly
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, 77230, USA
    Cancer 104:1213-20. 2005
    ..Even when treated with antiviral therapy, cytomegalovirus pneumonia (CMVp) is associated with high morbidity and mortality in immunocompromised patients. CMVp has been rarely reported in patients with lymphoma...
  90. ncbi Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004
    Syed Wamique Yusuf
    Department of Cardiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Medicine (Baltimore) 85:86-94. 2006
    ..The clinical spectrums of CPE and CNE differed in these patients with cancer. In patients with CNE, embolic cerebrovascular and fatal myocardial infarction were relatively common...
  91. ncbi Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma
    Amar Safdar
    Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Infect Dis 194:1394-7. 2006
    ..For each vaccine, the highest frequencies of increases in neutralizing antibody levels and the highest mean titers occurred in those given the 135- microg vaccine...
  92. ncbi Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)
    Georgios Chamilos
    Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Haematologica 91:986-9. 2006
    ..The complex and evolving epidemiology of IFI in severely immunocompromised patients is not well captured by current diagnostic methods...
  93. ncbi Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study
    Roy F Chemaly
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1402, USA
    Clin Infect Dis 44:964-7. 2007
    ..001). The use of neuraminidase inhibitor therapy seems to improve the outcome of influenza in patients with leukemia...
  94. ncbi Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions
    Amar Safdar
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:2664-71. 2006
    ..The authors evaluated the safety and efficacy of immune enhancement using recombinant interferon gamma1b (rIFN-gamma1b) in patients with cancer who received GTX for refractory, systemic, opportunistic infections...
  95. ncbi The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients
    Kenneth V I Rolston
    Section of Infectious Diseases, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas, M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 402, Houston, TX 77030, USA
    Int J Infect Dis 10:223-30. 2006
    ....
  96. ncbi Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies
    Gloria N Mattiuzzi
    Department of Leukemia, Unit 428, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, USA
    Antimicrob Agents Chemother 50:143-7. 2006
    ..In conclusion, intravenous itraconazole and caspofungin provided similar protection against invasive fungal infection during induction chemotherapy, and both drugs were well tolerated...
  97. ncbi Posaconazole: a broad-spectrum triazole antifungal
    Harrys A Torres
    Department of Infectious Diseases, Infection Control and Employee Health, University of Texas M D Anderson Cancer Center, Houston, Texas 77030-4009, USA
    Lancet Infect Dis 5:775-85. 2005
    ..Posaconazole has shown promising clinical efficacy against life-threatening fungal infections that are often refractory to the currently available antifungal therapies-eg, invasive aspergillosis, fusariosis, and the emerging zygomycosis...
  98. ncbi Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients
    Ray Y Hachem
    Department of Infectious Diseases, The University of Texas M D Anderson Cancer Center, P O Box 301402, Houston, TX 77230 1402, USA
    Antimicrob Agents Chemother 51:1905-11. 2007
    ..aeruginosa and, hence, may be a useful or preferred alternative therapy for this infection in cancer patients...
  99. ncbi Mycobacterium kansasii infections in patients with cancer
    K L Jacobson
    Section of Infectious Diseases, Universtiy of Texas M D Anderson Cancer Center, Houston, USA
    Clin Infect Dis 31:628-31. 2000
    ..The infections responded well to rifampin-based antimycobacterial regimens. M. kansasii is an infrequent but serious cause of pulmonary and, occasionally, disseminated disease in patients with cancer...
  100. ncbi Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles
    Elizabeth R Ramos
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Oncologist 16:1049-60. 2011
    ..Invasive aspergillosis (IA) continues to be a leading cause of morbidity and mortality in hematologic malignancy (HM) patients. We evaluated the prognostic factors for IA in HM patients...
  101. ncbi Infections in patients with aplastic anemia: experience at a tertiary care cancer center
    Harrys A Torres
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 98:86-93. 2003
    ..Bacterial infections, especially those caused by gram-positive cocci, constitute the main cause of IE. Invasive mold infections, however, are the major cause of death in this patient population...